Griffin MD - Search Results

1

Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody.

Liew A, Baustian C, Thomas D, Vaughan E, Sanz-Nogués C, Creane M, Chen X, Alagesan S, Owens P, Horan J, Dockery P, Griffin MD, Duffy A, O'Brien T. Liew A, et al. Among authors: griffin md. Cell Transplant. 2018 Aug;27(8):1210-1221. doi: 10.1177/0963689718784862. Epub 2018 Jul 17. Cell Transplant. 2018. PMID: 30016879 Free PMC article.

2

The effects of CTLA-4Ig on acute lung allograft rejection: a comparison of intrabronchial gene therapy with systemic administration of protein.

Ugurlu MM, Griffin MD, O'Brien T, Tazelaar HD, Miller VM, McGregor CG. Ugurlu MM, et al. Among authors: griffin md. Transplantation. 2001 Jun 27;71(12):1867-71. doi: 10.1097/00007890-200106270-00029. Transplantation. 2001. PMID: 11455274

3

Immunological aspects of allogeneic mesenchymal stem cell therapies.

Griffin MD, Ritter T, Mahon BP. Griffin MD, et al. Hum Gene Ther. 2010 Dec;21(12):1641-55. doi: 10.1089/hum.2010.156. Hum Gene Ther. 2010. PMID: 20718666 Review.

4

Developing cell-specific antibodies to endothelial progenitor cells using avian immune phage display technology.

Bowes T, Hanley SA, Liew A, Eglon M, Mashayekhi K, O'Kennedy R, Barry F, Taylor WR, O'Brien T, Griffin MD, Finlay WJ, Greiser U. Bowes T, et al. Among authors: griffin md. J Biomol Screen. 2011 Aug;16(7):744-54. doi: 10.1177/1087057111407067. Epub 2011 May 18. J Biomol Screen. 2011. PMID: 21593485

5

Mesenchymal stem cell effects on T-cell effector pathways.

Duffy MM, Ritter T, Ceredig R, Griffin MD. Duffy MM, et al. Among authors: griffin md. Stem Cell Res Ther. 2011 Aug 11;2(4):34. doi: 10.1186/scrt75. Stem Cell Res Ther. 2011. PMID: 21861858 Free PMC article. Review.

6

Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?

Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T. Griffin MD, et al. Immunol Cell Biol. 2013 Jan;91(1):40-51. doi: 10.1038/icb.2012.67. Epub 2012 Dec 4. Immunol Cell Biol. 2013. PMID: 23207278 Review.

7

Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?

Griffin MD, Elliman SJ, Cahill E, English K, Ceredig R, Ritter T. Griffin MD, et al. Stem Cells. 2013 Oct;31(10):2033-41. doi: 10.1002/stem.1452. Stem Cells. 2013. PMID: 23766124 Review.

8

Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation.

Ryan AE, Lohan P, O'Flynn L, Treacy O, Chen X, Coleman C, Shaw G, Murphy M, Barry F, Griffin MD, Ritter T. Ryan AE, et al. Among authors: griffin md. Mol Ther. 2014 Mar;22(3):655-667. doi: 10.1038/mt.2013.261. Epub 2013 Nov 1. Mol Ther. 2014. PMID: 24184966 Free PMC article.

9

Autologous and allogeneic mesenchymal stem cells in organ transplantation: what do we know about their safety and efficacy?

Alagesan S, Griffin MD. Alagesan S, et al. Among authors: griffin md. Curr Opin Organ Transplant. 2014 Feb;19(1):65-72. doi: 10.1097/MOT.0000000000000043. Curr Opin Organ Transplant. 2014. PMID: 24370985 Review.

10

Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor.

Alagesan S, Griffin MD. Alagesan S, et al. Among authors: griffin md. Kidney Int. 2014 Apr;85(4):730-3. doi: 10.1038/ki.2013.405. Kidney Int. 2014. PMID: 24682117 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page